Furthermore, the data presented here prove that maintenance of elevated cytosolic serine levels by the OCM cytosolic enzyme SHMT1 is a key event in the control of adenocarcinoma cell motility, since the lack of SHMT1 heavily affects this property, while SHMT2 knockdown has no effect. The gene discussed is SHMT2; the disease is adenocarcinoma.